System/Device, Pharmacy Compounding(NEP)

薬局調剤システム この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。

米国回収

41 件

直近 2026.06.10

510(k)

0 件

PMA

0 件

不具合報告

1,231 件

分類情報

Product Code NEP
デバイス名 System/Device, Pharmacy Compounding

薬局調剤システム この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。

デバイスクラス クラス II
21 CFR 規制番号 880.5440
審査区分 届出免除(510(k) Exempt)
医療専門分野 一般病院用
定義 -
フラグ
該当なし
AI分析

薬局調剤システムは、医療機関の薬局において薬剤を調剤・調製する際に使用される機器またはシステムです。米国においてはクラスIIに分類され、通常クラスII機器は市販前届出(510(k))の対象となりますが、本品目は届出免除(510(k) Exempt)とされており、市販前届出を行わずに流通させることが認められています。

米国市場での動向

本製品は届出免除(510(k) Exempt)の分類のため、510(k) およびPMAの届出件数は確認されていません。不具合報告は累計で約1,200件寄せられており、その大半が不具合(Malfunction)に関するもので、死亡7件、傷害約40件が報告されています。直近5年間では約320件の報告があり、主な問題としてFluid/Blood Leak(液体・血液の漏出)、Break(破損)、Application Program Problem: Dose Calculation Error(投与量計算エラー)が挙げられています。回収は累計約40件で、クラスI(最重篤)が7件、クラスIIが28件含まれており、最新の回収は2026年4月に開始されています。

この分析は公開データ(openFDA・JMDN 対応情報)をもとに AI が生成した参考情報です。市場データは2026年8月時点の集計に基づきます。

関連 product code

同じ 21 CFR 880.5440 に分類される product code(19 件)

No.product code機器名クラス専門分野510(k)PMA不具合回収
1FPA

Set, Administration, Intravascular

血管内投与セット

II一般病院用1,175—349,1761,083 件
2LHI

Set, I.V. Fluid Transfer

輸液移送用セット

II一般病院用206—14,37262 件
3FPB

Filter, Infusion Line

輸液ラインフィルタ

II一般病院用99—1,1708 件
4FMG

Stopcock, I.V. Set

点滴セット用ストップコック

II一般病院用89—6,005205 件
5FPK

Tubing, Fluid Delivery

輸液用チューブ

II一般病院用64—84728 件
6ONB

Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System

閉鎖式抗悪性剤・有害薬剤再溶解及び移送システム

II一般病院用41—4,83071 件
7CAK

Microfilter, Blood Transfusion

輸血用マイクロフィルタ

II一般病院用36—1,6581 件
8BRZ

Set, Blood Transfusion

輸血セット

II一般病院用30—1,84024 件
9QBP

Cap, Device Disinfectant

針なしアクセスバルブ用消毒キャップ

II一般病院用22—242 件
10PQH

Iodinated Contrast Media Transfer Tubing Set

ヨード造影剤移送用チューブセット

II一般病院用6—1—
11PWH

Administrations Sets With Neuraxial Connectors

神経麻酔用コネクタ付投与セット

II一般病院用4—53—
12MJF

Check Valve, Retrograde Flow (In-Line)

逆流防止用チェックバルブ(インライン型)

II一般病院用1———

機器名の日本語訳は AI により自動生成したものです。正確には英語原文をご確認ください。

FDA のデバイスクラスは 3 段階(クラス I〜III)、日本の医療機器は 4 段階(クラス I〜IV)で分類されており、 1 対 1 では対応しません。 リスク区分の考え方が異なるため、参考情報としてご利用ください。

米国での回収・承認・不具合報告

無料会員 1,000名 突破

回収・承認・不具合報告の明細の閲覧は会員限定です

無料で会員登録する
この企業の Warning Letter を検索: Baxter Healthcare CorporationOmnicell, Inc.OmniCell, Inc.
回収番号クラス回収開始日企業理由ステータス
Z-2262-2026 NEPクラス II2026.04.22Baxter Healthcare Corporation

Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slower transfers of ingredients, or system alarms. This issue may lead to clinical effects such as electrolyte imbalance, metabolic instability, delayed recovery, etc.

対応中
Z-2047-2026 NEPクラス I(最重篤)2026.03.25Omnicell, Inc.

Potential for mislabeled syringe produced by the i.v.STATION device.

対応中
Z-1617-2023 NEPクラス II2023.03.27OmniCell, Inc.

IVX Station does not account for inherent scale inaccuracy or variability, could result in a preparation being passed that is outside of the dose accuracy stated in the product labeling

対応中
Z-1376-2022 NEPクラス I(最重篤)2022.06.22Baxter Healthcare Corporation

There is a potential risk of medication error when using specific Abacus Order Entry & Calculation software.

終了
Z-1475-2021 NEPクラス II2021.03.31Smiths Medical ASD Inc.

Specific lots of Medex High Pressure Adaptors, Rotators, Manifolds, Stopcocks and Tubing and Medex LogiCal Kits may have been manufactured with insufficient or incomplete welds. These are components for various cardiac kits including pressure monitoring devices and interventional imaging devices.

終了
Z-1472-2021 NEPクラス II2021.03.31Smiths Medical ASD Inc.

Specific lots of Medex High Pressure Adaptors, Rotators, Manifolds, Stopcocks and Tubing and Medex LogiCal Kits may have been manufactured with insufficient or incomplete welds. These are components for various cardiac kits including pressure monitoring devices and interventional imaging devices.

終了
Z-0719-2021 NEPクラス II2020.11.23B Braun Medical, Inc.

There is the potential for the compounding system to not immediately interrupt compounding and alert user to the presence of an air bubble exceeding 3% of the ordered volume for an ingredient. This could result in a a compounded drug that does not meet the specified accuracy range for an individual ingredient.

終了
Z-0718-2021 NEPクラス II2020.11.23B Braun Medical, Inc.

There is the potential for the compounding system to not immediately interrupt compounding and alert user to the presence of an air bubble exceeding 3% of the ordered volume for an ingredient. This could result in a a compounded drug that does not meet the specified accuracy range for an individual ingredient.

終了
Z-0717-2021 NEPクラス II2020.11.23B Braun Medical, Inc.

There is the potential for the compounding system to not immediately interrupt compounding and alert user to the presence of an air bubble exceeding 3% of the ordered volume for an ingredient. This could result in a a compounded drug that does not meet the specified accuracy range for an individual ingredient.

終了
Z-2343-2018 NEPクラス II2018.06.04B. Braun Medical, Inc.

There is a potential for valves on the 26-Lead Transfer Set to be incorrectly oriented. When a transfer set with an incorrectly oriented valve is installed on the system, there is potential for unintended admixture.

終了
Z-0989-2017 NEPクラス II2016.11.23HEALTH ROBOTICS S.R.L.

The firm has initiated a product correction due to a bag carousel motor error causing misalignment and resulting in a mislabeling of final IV bag preparations.

終了
Z-2264-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2263-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2262-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2261-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2260-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2259-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2258-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-2257-2016 NEPクラス II2016.06.23The Metrix Company

An issue was identified after a redesign of the auto compounding device. The compounder cannot meet the designed accuracy specification when dispensing into bags. After reviewing the initial design of the device, it was determined the dispensing volume validation was not properly done and none of the compounders on the market can meet the stated specifications.

終了
Z-1369-2016 NEPクラス II2016.03.08ICU Medical, Inc.

ICU Medical Inc. has received a report of compounded volumes not meeting the accuracy specification by the Diana Compounding System when mixing volumes under 5ml.

終了

510(k)(市販前届出)

この product code の 510(k) 情報はありません。

出典の openFDA は各 510(k) の主要(primary)product code のみを収録しているため、副次コードを含む FDA 公式データベースの検索結果とは件数が異なる場合があります。 FDA 510(k) データベースで確認

PMA(市販前承認)

この product code の PMA 情報はありません。

不具合報告(MAUDE)トレンド

米国不具合報告検索で詳しく見る

出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。

報告の存在は、機器と事象の因果関係を意味しません。報告件数を機器間の不具合発生率の比較に用いることはできません。

各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。

不具合報告データを読み込み中...

出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。

取得日: 2026.09.28

各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。